Recruiting A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010). NCT05947851 Conditions CLL, Chronic Disease, Disease Attributes, +18 more Locations Highlands Oncology Group ( Site 5405) — Springdale, Arkansas, United States MemorialCare Health System - Long Beach Medical Center ( Site 5421) — Long Beach, California, United States Memorial Hospital West ( Site 5410) — Pembroke Pines, Florida, United States Oregon Health and Science University ( Site 5425) — Portland, Oregon, United States View all 55 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed A Multi-Center Study of Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Patients With Treatment naïve Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) NCT02264574 Conditions Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more Locations Site Reference ID/Investigator# 0241 — La Jolla, California, United States Site Reference ID/Investigator# 0844 — Fort Myers, Florida, United States Site Reference ID/Investigator# 0763 — West Palm Beach, Florida, United States Site Reference ID/Investigator# 071 — Louisville, Kentucky, United States View all 71 locations View more locations Show fewer locations Loading locations... View Trial Details
